Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",26694,123,1.13 [0.87-1.47],0.3549002778761061
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27439,207,1.12 [0.92-1.38],0.2597032767030873
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27160,1335,1.18 [1.09-1.28],3.379062544684361e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Candidiasis,27472,473,1.21 [1.05-1.38],0.0067235026810251
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26615,3519,1.15 [1.09-1.21],3.047164928939574e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),26854,2893,1.20 [1.13-1.27],8.042261813280341e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27176,1377,1.12 [1.03-1.21],0.005028860581016
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27358,91,1.19 [0.88-1.63],0.2600527281556393
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25607,824,1.17 [1.05-1.29],0.0033668122999876
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24758,961,1.29 [1.18-1.42],9.265132077652797e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,24787,261,1.25 [1.04-1.50],0.0160391390718537
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19285,1684,1.23 [1.14-1.32],1.946932416178698e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24561,378,1.39 [1.20-1.61],1.7930018119235346e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27406,1607,1.11 [1.03-1.19],0.0055352253621898
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Mycoses,27537,538,1.21 [1.06-1.37],0.0036289217740177
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26774,949,1.25 [1.14-1.38],3.99920930493778e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27482,911,1.15 [1.04-1.27],0.0045438195816222
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26006,207,1.13 [0.92-1.39],0.2354015759103085
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27597,45,1.44 [0.93-2.24],0.1014445419616988
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27366,795,1.15 [1.04-1.28],0.0084005235451522
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27351,84,1.03 [0.75-1.41],0.8758776019609198
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27499,195,1.27 [1.03-1.56],0.0274608700384537
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27480,176,1.20 [0.96-1.49],0.1096229873846292
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26165,340,1.25 [1.07-1.47],0.0055646381439931
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,26088,263,0.99 [0.83-1.18],0.9080031659241748
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,25930,131,1.10 [0.85-1.42],0.4878622312667136
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27573,37,1.75 [1.10-2.79],0.0185781821468872
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27523,160,1.43 [1.14-1.81],0.0023429875640519
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral warts,27410,47,1.32 [0.86-2.02],0.1981444911421187
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27440,77,1.47 [1.05-2.05],0.0244186839023967
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm,27326,239,0.93 [0.77-1.12],0.4210087709067165
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27492,70,1.01 [0.72-1.44],0.9351780472514204
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27489,69,0.86 [0.61-1.21],0.3847554437454709
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27306,1233,1.04 [0.95-1.13],0.414565434294157
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of meninges,27570,81,1.07 [0.77-1.48],0.6821682447323225
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27530,64,0.94 [0.65-1.35],0.7346901216391247
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27564,137,0.97 [0.76-1.25],0.83816519507856
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm of ovary,27512,181,0.95 [0.77-1.19],0.6766394280352961
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27575,280,0.86 [0.72-1.02],0.0779385103292751
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Caecum,27581,252,0.98 [0.81-1.18],0.8062918142954072
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27509,66,1.20 [0.84-1.72],0.3266326169622848
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Descending colon,27578,156,0.90 [0.71-1.14],0.3794209264619096
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Rectum,27539,280,0.94 [0.79-1.12],0.4756256289905733
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27489,499,1.13 [0.99-1.29],0.075692280707012
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27576,302,0.97 [0.82-1.15],0.7027672877183488
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Carcinoma in situ of breast,22368,139,1.03 [0.80-1.32],0.8272199623927009
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22459,168,0.99 [0.79-1.24],0.919789493824842
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",22436,31,0.77 [0.47-1.28],0.3133210398620731
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",22474,69,0.93 [0.66-1.32],0.6889729808438443
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27529,137,0.91 [0.71-1.16],0.4414290499982218
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Haemangioma, any site",27530,135,0.92 [0.71-1.18],0.5159490005880805
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Leiomyoma of uterus,26606,585,0.96 [0.85-1.08],0.4850664428831915
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Lung cancer and mesothelioma,19802,316,0.93 [0.78-1.11],0.4312727616002926
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Lymphoid leukaemia,22442,37,0.93 [0.57-1.50],0.7589841391223505
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22580,175,1.22 [0.97-1.53],0.0832410735976068
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",22514,109,1.31 [0.98-1.74],0.0662550216193753
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22595,190,1.01 [0.82-1.24],0.959892536795516
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",22470,65,1.34 [0.93-1.93],0.1133842374406357
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",22475,70,0.97 [0.68-1.38],0.8707371800718019
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",22463,58,1.45 [0.98-2.13],0.0631256924250186
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22547,142,0.83 [0.66-1.06],0.1396150787988813
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",22507,102,1.13 [0.84-1.50],0.4171716894156422
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",22491,86,1.14 [0.83-1.57],0.4207274090396075
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",22447,42,0.89 [0.57-1.38],0.5905586484941439
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,22486,81,0.85 [0.62-1.18],0.3337832218263101
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi,27336,233,1.22 [1.00-1.48],0.0452307961604225
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanocytic naevi of trunk,27550,80,1.07 [0.77-1.49],0.6994910366220891
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Melanoma in situ,22440,89,0.87 [0.64-1.18],0.3688144393755937
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",22487,82,0.90 [0.66-1.25],0.5392721126167077
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22558,153,1.12 [0.88-1.42],0.3649752460505151
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",22633,228,0.92 [0.75-1.12],0.3888629776159973
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",22498,93,0.94 [0.69-1.27],0.6828414263459786
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Other benign neoplasms of skin,27372,171,0.93 [0.74-1.16],0.506943166235136
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23358,953,0.92 [0.84-1.01],0.0781077054496088
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23398,993,0.92 [0.84-1.01],0.0839439292501376
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27291,375,1.19 [1.03-1.39],0.0221793134911198
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,25575,103,1.11 [0.83-1.48],0.4940547405688205
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,26985,69,1.51 [1.06-2.14],0.0213301796190768
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26588,2989,1.19 [1.12-1.25],5.754664749086314e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,25945,37,1.67 [1.04-2.70],0.0349491177269201
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27192,49,0.98 [0.65-1.48],0.9225785929197988
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27020,1548,1.24 [1.15-1.33],2.3632993783511225e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27020,1548,1.24 [1.15-1.33],2.3632993783511225e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,25542,70,1.82 [1.28-2.58],0.0008874957085219
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27189,1281,1.23 [1.13-1.33],7.498928799481143e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27265,122,1.25 [0.96-1.62],0.0972417375422573
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,26969,53,1.29 [0.86-1.93],0.2155445767133708
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,26974,58,1.01 [0.69-1.49],0.9558655719501958
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27381,238,1.38 [1.14-1.67],0.0008684512311275
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27487,62,1.35 [0.94-1.94],0.1060700338549215
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27343,200,1.40 [1.14-1.73],0.0013703734732573
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,26036,128,0.90 [0.69-1.17],0.4251448425652242
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,22220,254,1.17 [0.98-1.41],0.0895041408664245
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26173,67,0.88 [0.62-1.26],0.4802455819510191
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26168,62,0.76 [0.53-1.07],0.1178457463965046
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,22020,54,1.24 [0.82-1.85],0.3080997891517403
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,25318,72,1.03 [0.73-1.45],0.8777063885699034
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,24951,247,0.91 [0.76-1.10],0.3206144852394579
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",27161,516,1.23 [1.08-1.40],0.0017383493171025
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,26930,285,1.09 [0.91-1.30],0.3457489406502584
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,26731,86,1.21 [0.88-1.67],0.2354951643403735
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27196,1950,1.08 [1.01-1.16],0.0181223273217624
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24421,1897,1.07 [1.00-1.15],0.0386443973440682
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",22025,59,1.24 [0.84-1.82],0.2729653519645466
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",24472,117,0.94 [0.72-1.23],0.6564446325640293
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,22248,282,1.28 [1.08-1.53],0.0055969929088378
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,22013,47,1.29 [0.84-1.99],0.2477334273616663
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,25130,3164,0.96 [0.91-1.01],0.1466460964072005
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,22160,194,1.18 [0.95-1.46],0.1276932506187434
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,22499,533,1.19 [1.05-1.35],0.0072095605061702
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27490,373,1.12 [0.96-1.30],0.1415096712116348
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27303,186,1.17 [0.95-1.45],0.1426214208950412
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,22067,101,1.13 [0.85-1.52],0.3999680903102249
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",22023,57,1.42 [0.96-2.10],0.0799459254308794
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26703,2348,0.98 [0.92-1.04],0.5066146034448529
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,22174,208,1.38 [1.13-1.69],0.0016170900513809
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,22180,214,1.26 [1.03-1.53],0.0239496023393191
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22500,534,1.03 [0.90-1.16],0.6947090468718431
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,22060,94,1.30 [0.96-1.76],0.0923570528697353
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27293,176,1.21 [0.97-1.50],0.0939748845724754
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,22598,632,1.25 [1.12-1.41],0.0001613129640985
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,22533,567,1.11 [0.98-1.26],0.0886183127200876
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,24775,71,1.18 [0.83-1.67],0.3486677829330946
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,26690,4724,1.03 [0.99-1.08],0.148593731053586
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,24433,78,0.82 [0.59-1.13],0.2183836687286653
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,24443,88,1.09 [0.79-1.49],0.6085134665360268
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27397,2090,0.93 [0.88-0.99],0.0341032475667899
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27402,2089,0.93 [0.88-0.99],0.0302601267698724
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,24438,83,1.01 [0.73-1.38],0.971373144012302
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27184,1596,1.03 [0.96-1.11],0.4253093970903077
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23501,1535,1.19 [1.10-1.28],8.225253483773095e-06
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27582,182,1.52 [1.23-1.88],0.0001124811943124
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,26703,58,1.09 [0.74-1.62],0.6560051070113603
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,25722,134,1.32 [1.02-1.70],0.0336303960820039
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,25790,202,1.09 [0.89-1.34],0.4136954539568004
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",22232,266,1.24 [1.03-1.48],0.0214174247034962
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25756,140,1.99 [1.56-2.54],2.2401408996137392e-08
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1718,47,1.38 [0.92-2.09],0.1235064999201228
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1832,185,1.42 [1.16-1.73],0.0008097246425466
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25641,25,1.52 [0.85-2.70],0.1570689559195993
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1701,31,2.25 [1.39-3.64],0.0009132904265735
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27109,1493,0.94 [0.87-1.01],0.0766936603587572
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,26986,341,1.11 [0.94-1.30],0.2153265721441759
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,25188,484,1.15 [1.01-1.31],0.0359515013755838
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22694,728,1.20 [1.08-1.34],0.0008151296167145
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27496,230,1.06 [0.87-1.28],0.5771843531010363
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),26581,54,1.26 [0.84-1.88],0.2659078759792896
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Angina pectoris,26057,888,1.07 [0.97-1.19],0.1496333998821033
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,26625,98,1.28 [0.95-1.73],0.105986901165797
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,26562,35,1.89 [1.16-3.10],0.0109952889595006
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",26677,150,1.13 [0.89-1.44],0.3140981541882232
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17941,1476,1.10 [1.02-1.19],0.0167938126610617
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,AV-block,24159,242,1.25 [1.03-1.51],0.0231332347941989
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27553,303,0.99 [0.84-1.18],0.9359089423713178
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiac arrest,16595,130,1.33 [1.03-1.73],0.0308834531735273
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24053,136,1.49 [1.16-1.92],0.0019537787925967
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",23996,79,1.09 [0.78-1.53],0.5961832057023775
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27593,34,0.42 [0.01-19.33],0.6570583807250969
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Conduction disorders,24650,733,1.25 [1.12-1.40],5.06931960343248e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26672,1515,1.02 [0.95-1.10],0.5211057481515069
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,24809,7288,0.99 [0.95-1.02],0.5001289038904623
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26071,245,1.07 [0.89-1.30],0.4523435708999154
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Endocarditis,23979,62,1.14 [0.78-1.65],0.500974845743118
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27498,861,1.25 [1.14-1.39],8.3287584671634e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertension,25441,6163,0.96 [0.92-0.99],0.0176213435355858
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",25454,6176,0.96 [0.92-0.99],0.0214543632254619
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27481,41,1.73 [1.10-2.72],0.016852350932495
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19442,164,1.40 [1.11-1.77],0.0041072599920649
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19378,100,1.68 [1.25-2.24],0.0004967039045075
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypotension,27455,1116,1.19 [1.09-1.30],0.0001276890707461
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,26834,98,0.94 [0.69-1.26],0.6594770773634517
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26869,1700,1.04 [0.97-1.11],0.3173877454281436
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27278,459,1.02 [0.89-1.17],0.7813096249371384
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,24220,303,1.14 [0.97-1.36],0.1195823864639465
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27366,611,1.05 [0.93-1.18],0.4178368122011001
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25658,489,1.06 [0.93-1.21],0.3690198888733248
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27571,89,1.03 [0.75-1.41],0.841770140486291
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27589,241,1.16 [0.96-1.41],0.115623509942888
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Oesophageal varices,25863,37,1.42 [0.88-2.30],0.1500352272494221
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other aneurysm,26586,59,1.58 [1.08-2.31],0.0195219385671986
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,24274,357,1.09 [0.93-1.28],0.2665921619560727
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,26594,67,1.38 [0.96-1.98],0.0798016751513997
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26719,192,1.24 [1.00-1.54],0.0454697520408037
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,24072,155,1.15 [0.91-1.46],0.2375081817325336
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other disorders of veins,25920,94,1.11 [0.82-1.50],0.4988193745768265
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,25870,44,1.32 [0.85-2.05],0.2175418275263812
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,26339,40,0.68 [0.44-1.06],0.0894521317406568
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,25992,166,1.08 [0.86-1.36],0.4833698754917356
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24724,807,1.21 [1.09-1.34],0.0002767112474027
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,26383,44,1.12 [0.72-1.73],0.6195736096554885
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27032,505,1.36 [1.19-1.55],5.180730404726942e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27015,323,1.37 [1.17-1.62],0.0001332078455835
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",26846,547,1.05 [0.93-1.19],0.4510052065831735
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16759,294,1.26 [1.06-1.49],0.0098713378031511
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26790,277,1.31 [1.10-1.56],0.0029166648785182
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26153,327,1.09 [0.93-1.28],0.2934341301315082
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27137,445,1.14 [0.99-1.30],0.0730830135546948
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27517,593,1.30 [1.15-1.47],1.946088042631067e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,24138,221,1.45 [1.19-1.77],0.0002583280763653
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27006,314,1.40 [1.18-1.65],7.482282173680383e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26459,160,1.16 [0.92-1.47],0.2044886795520069
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27271,535,0.99 [0.87-1.13],0.8933742336051054
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27246,583,0.99 [0.88-1.12],0.9118821679178288
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,26800,71,0.85 [0.60-1.20],0.3580451635757211
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,26573,46,0.87 [0.57-1.34],0.530455079848873
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27040,221,0.88 [0.72-1.07],0.1882670263780199
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26961,206,0.97 [0.79-1.18],0.744141859351071
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Varicose veins,26291,465,1.17 [1.02-1.34],0.0267082674381129
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26538,97,1.49 [1.10-2.01],0.0094214242647969
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27380,705,1.12 [1.00-1.25],0.0502936089573753
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27550,216,0.86 [0.70-1.04],0.1261238733751433
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24521,1863,1.05 [0.98-1.12],0.1686745086045933
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Any mental disorder,26980,4322,1.04 [1.00-1.09],0.0656378760746543
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27519,257,0.88 [0.73-1.05],0.1625615162613276
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24628,1970,1.07 [1.00-1.15],0.0394770069913554
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22753,95,1.05 [0.78-1.42],0.7429187082106969
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Smoking dependency,27187,1192,1.03 [0.94-1.13],0.4914445728611062
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24033,1375,1.04 [0.96-1.13],0.3168528650530799
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Vascular dementia,27093,103,1.34 [1.00-1.79],0.0512261898901322
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Alzheimer disease,27597,353,1.12 [0.95-1.31],0.1676722685124224
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",18850,59,1.40 [0.95-2.07],0.08626081301757
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Bell's palsy,25417,84,1.24 [0.90-1.71],0.1812728430246445
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,25976,643,1.05 [0.93-1.18],0.4175239007192046
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral cysts,27185,220,0.94 [0.77-1.14],0.525652771389141
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27523,281,1.14 [0.96-1.36],0.139447773968407
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,27116,40,1.16 [0.72-1.85],0.5479662224290327
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27582,47,0.98 [0.64-1.50],0.9345890344452874
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27020,55,0.97 [0.65-1.44],0.877161852900266
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Epilepsy,26104,285,1.45 [1.22-1.73],2.9314737160691244e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27183,1364,1.09 [1.01-1.18],0.026700134983174
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27548,518,1.11 [0.97-1.26],0.1306145538048109
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26959,2925,1.11 [1.05-1.17],0.0002140597974868
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Generalized epilepsy,27224,47,2.23 [1.46-3.41],0.0001924167672954
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Hemiplegia,27465,223,1.16 [0.95-1.41],0.1459709121368518
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Hydrocephalus,27032,67,0.80 [0.56-1.14],0.2124270408326747
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27576,78,1.17 [0.84-1.63],0.3529516987064479
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,25460,127,0.98 [0.76-1.27],0.889651762042201
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,25400,67,1.10 [0.77-1.58],0.5943357391209425
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Memory loss,26969,98,1.23 [0.91-1.66],0.1684150957809697
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Migraine,26334,515,1.10 [0.97-1.25],0.1434459450975125
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27482,465,1.09 [0.95-1.24],0.2383875076442682
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Motor neuron disease,18940,122,1.02 [0.78-1.33],0.8954678495912312
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27374,142,1.05 [0.82-1.35],0.704944416890974
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26741,1408,1.05 [0.98-1.14],0.1846204815867191
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Neurological diseases,25975,3839,1.07 [1.02-1.12],0.0057401856521441
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,27231,155,1.28 [1.01-1.62],0.0431003771335346
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25759,426,0.98 [0.85-1.13],0.814165964885707
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27538,238,1.13 [0.93-1.36],0.215209090574563
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,22211,659,1.16 [1.03-1.30],0.0127747526820179
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27033,68,1.39 [0.97-1.98],0.0711574553226047
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27089,124,1.16 [0.89-1.50],0.2765194091483691
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,27221,191,1.17 [0.95-1.45],0.1431239129239114
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,25428,95,1.24 [0.92-1.67],0.1598589194068241
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other headache syndromes,25891,72,0.94 [0.67-1.32],0.7370939379771667
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other neurological diseases,27473,508,1.07 [0.94-1.22],0.3207217254479395
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other sleep disorders,26229,410,1.07 [0.93-1.24],0.3473735380631548
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Parkinson's disease,27571,312,1.01 [0.86-1.20],0.8815688639115785
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27046,81,0.79 [0.58-1.09],0.1531898548953205
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Restless leg syndrome,27595,106,1.11 [0.83-1.47],0.4867974329823027
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Sleep apnoea,27419,324,0.98 [0.84-1.15],0.8090113087373687
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27341,41,1.41 [0.88-2.24],0.1503140188110114
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27586,152,1.04 [0.82-1.32],0.7517454990307821
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,25402,69,0.79 [0.56-1.12],0.1875915556749814
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27597,357,1.11 [0.95-1.30],0.189231447022097
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),27053,100,1.31 [0.97-1.76],0.0794630516731602
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27012,110,0.98 [0.74-1.30],0.8969148388918219
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27129,482,1.04 [0.91-1.19],0.5342339924362853
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27450,171,1.71 [1.38-2.12],1.1887061687468333e-06
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26478,63,1.08 [0.74-1.57],0.686220707643193
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26469,54,0.98 [0.65-1.46],0.9146879516677976
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27476,60,1.13 [0.77-1.65],0.5351483383716578
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,27310,165,0.91 [0.72-1.14],0.3927802987523456
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1708,37,2.32 [1.50-3.58],0.0001439807643039
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2051,69,1.62 [1.16-2.27],0.0045111203345577
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,26994,92,0.97 [0.71-1.31],0.8200197790807513
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27419,1069,1.18 [1.08-1.29],0.0003086770436434
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27176,761,0.97 [0.87-1.08],0.6026402142443608
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26714,299,0.95 [0.80-1.12],0.5189681206109433
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27501,854,1.02 [0.92-1.12],0.7572259844815206
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27580,65,1.09 [0.76-1.56],0.6550623630142727
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27420,773,1.03 [0.93-1.15],0.5328690785773369
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27548,403,1.07 [0.92-1.24],0.3679456925617543
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27499,204,0.91 [0.74-1.11],0.3383293768029928
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26454,39,1.29 [0.80-2.06],0.2929025748595991
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26464,49,0.86 [0.57-1.31],0.4880121736693475
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26483,68,0.76 [0.53-1.07],0.1172762046638627
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27506,715,1.06 [0.95-1.19],0.2684597561940612
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,26972,181,1.02 [0.82-1.27],0.841901161218641
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,26709,62,1.31 [0.90-1.90],0.1547489354792704
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,27243,98,1.08 [0.80-1.45],0.6284915238687967
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27458,313,1.05 [0.89-1.24],0.5761509272763594
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,26859,212,0.97 [0.79-1.19],0.7804946203012118
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27431,136,1.06 [0.83-1.37],0.6248578897073314
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27263,472,1.03 [0.90-1.18],0.6812600307698747
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27053,151,1.09 [0.86-1.38],0.4930267327465566
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,25787,2534,1.08 [1.02-1.14],0.0136228437180002
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27416,271,1.07 [0.90-1.28],0.452767311839002
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27571,157,1.25 [0.99-1.58],0.0627341174910385
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26812,397,0.99 [0.85-1.15],0.9048215811298248
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,27205,60,1.09 [0.74-1.59],0.6635353082585622
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27566,51,1.20 [0.80-1.82],0.3808520880307835
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26508,93,1.06 [0.78-1.45],0.6896533817598842
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26569,154,0.96 [0.76-1.22],0.744599340746946
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26457,107,1.17 [0.88-1.56],0.2779780711424481
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,26720,73,0.94 [0.66-1.32],0.7134800770253986
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",26411,61,0.98 [0.67-1.43],0.9152081950444112
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,26910,119,1.29 [0.98-1.69],0.0665395346125723
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",26969,178,1.01 [0.81-1.26],0.9301429883627294
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,26551,136,0.98 [0.76-1.26],0.8546833026768058
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,26448,98,1.34 [0.99-1.81],0.0549335790704124
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,26425,75,1.22 [0.87-1.71],0.257643424778108
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,25362,2109,1.14 [1.07-1.21],8.559919480685033e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26501,86,0.71 [0.52-0.96],0.0256094518560243
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27329,427,1.02 [0.89-1.18],0.7639182182476415
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,26950,48,1.02 [0.66-1.56],0.9343389353875045
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27073,171,1.25 [1.00-1.57],0.0490395321984479
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27356,118,1.01 [0.77-1.32],0.9435238656905084
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27549,118,0.80 [0.62-1.05],0.104232003522452
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27469,143,1.19 [0.93-1.52],0.1720700043637036
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,27306,68,0.83 [0.58-1.17],0.2856123996303913
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,27307,69,0.90 [0.63-1.28],0.558877090370218
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27494,817,1.15 [1.03-1.27],0.009301672521932
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27238,561,1.20 [1.06-1.36],0.0037611624450096
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,26800,123,1.65 [1.27-2.14],0.000192155427902
PLA2G10,Group 10 secretory phospholipase A2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,26762,85,0.88 [0.64-1.21],0.431679087977341
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute pharyngitis,27325,86,0.80 [0.59-1.08],0.1496722986796267
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27472,233,0.95 [0.78-1.15],0.5827412098865941
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27303,64,0.92 [0.64-1.33],0.6543223760143694
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,All influenza,25865,130,1.63 [1.26-2.11],0.000190381441113
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),25863,128,1.64 [1.26-2.12],0.0001904851432182
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),19612,126,1.25 [0.96-1.62],0.0941379681325555
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Allergic rhinitis,27439,285,0.84 [0.71-1.00],0.0525797312451608
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21374,2080,1.03 [0.97-1.10],0.3289770866547207
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21541,2055,1.02 [0.96-1.09],0.4879266200453392
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27172,124,1.37 [1.05-1.78],0.0186778222866239
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",25800,65,1.49 [1.04-2.15],0.0302547629520872
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Bronchiectasis,23861,406,1.52 [1.32-1.76],1.6376488970757912e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",23523,68,0.94 [0.66-1.33],0.7166996242692618
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26432,2977,1.09 [1.03-1.15],0.0018797634208542
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26308,62,1.08 [0.74-1.57],0.6926459362872206
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic sinusitis,26394,148,1.06 [0.84-1.36],0.612456481120967
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27423,1055,1.19 [1.09-1.31],0.0001823144713261
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Deviated nasal septum,26319,73,0.86 [0.61-1.20],0.3719160559206381
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25493,5188,1.06 [1.02-1.11],0.0033938049509956
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26575,329,0.93 [0.79-1.09],0.3455183105043946
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Early onset COPD,26680,312,1.25 [1.06-1.49],0.0084244851551239
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Emphysema,23732,277,1.40 [1.16-1.69],0.0004287051040866
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25956,231,1.77 [1.46-2.14],5.7363963844091185e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27395,1660,1.15 [1.07-1.24],0.0001578010777392
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,25996,271,1.65 [1.38-1.97],3.768826979466065e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Later onset COPD,26684,743,1.16 [1.04-1.30],0.0069999800256633
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27588,230,1.21 [0.99-1.47],0.0588472290926134
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Nasal polyp,26316,70,0.86 [0.61-1.21],0.3861934462697839
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27369,919,1.30 [1.18-1.44],7.517259525216239e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,27405,1759,1.10 [1.03-1.18],0.007330857557125
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27034,788,0.95 [0.86-1.06],0.3572873176921854
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other pleural conditions,25682,36,0.70 [0.44-1.12],0.1385052703495058
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27514,347,1.55 [1.32-1.81],5.219166493758673e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27507,1188,1.10 [1.01-1.20],0.0285298839407469
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pleural effusion,26497,851,1.14 [1.03-1.27],0.0093568496528513
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pleural plaque,25693,47,1.04 [0.67-1.60],0.8573195285044943
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27164,1429,1.17 [1.08-1.26],0.0001089554013051
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27560,202,1.27 [1.03-1.56],0.0240431803296074
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pneumothorax,25736,90,1.38 [1.01-1.89],0.0445890231172373
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pollen allergy,27563,238,0.86 [0.71-1.03],0.1062574782971658
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pulmonary oedema,27231,64,1.26 [0.88-1.81],0.2110789864508247
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,19538,52,1.08 [0.70-1.68],0.7198806817414303
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27343,893,1.33 [1.21-1.47],8.663357847825738e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26531,285,0.84 [0.71-1.00],0.0508739780360228
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Viral pneumonia,25949,214,1.16 [0.95-1.42],0.1363263925664636
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27187,169,1.01 [0.81-1.26],0.9525883132560996
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13334,105,1.06 [0.80-1.41],0.6873819875736087
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19674,38,1.06 [0.66-1.71],0.799115568231302
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute appendicitis,27410,140,0.96 [0.75-1.24],0.7639777127355502
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute gastritis,20714,88,0.88 [0.64-1.21],0.4412368055110757
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute pancreatitis,25278,163,1.08 [0.86-1.36],0.4955876339072178
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Acute peritonitis,27015,86,0.99 [0.72-1.36],0.9565450564833936
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,26712,33,0.97 [0.58-1.63],0.922730820560232
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Barrett oesophagus,20969,343,1.13 [0.96-1.33],0.1312614948524532
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",25195,80,1.30 [0.94-1.80],0.113787503487494
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27161,80,1.29 [0.94-1.79],0.1189521512770743
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholecystitis,25300,185,1.09 [0.88-1.35],0.4239619484707407
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Cholelithiasis,26311,1196,1.02 [0.94-1.11],0.6255367462472681
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Chronic gastritis,20970,344,1.21 [1.04-1.42],0.0170647775452889
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,25158,43,0.91 [0.58-1.42],0.675123585400345
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27512,72,1.37 [0.97-1.93],0.0703250371758896
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Coeliac disease,26021,156,1.57 [1.24-1.99],0.0002138328569587
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Collagenous colitis,25686,113,1.33 [1.00-1.75],0.0490740945464139
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27456,150,0.91 [0.72-1.15],0.4150488575186304
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Constipation,27246,1737,1.10 [1.03-1.18],0.0070157015291843
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn disease,25667,94,1.34 [0.99-1.82],0.0618403611629034
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27231,70,1.43 [1.00-2.03],0.04798336881098
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25670,97,1.29 [0.95-1.74],0.1027950532310895
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Dental caries,26764,229,1.07 [0.88-1.29],0.5006538770881841
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25969,2473,1.07 [1.00-1.13],0.0360576605605155
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of appendix,27453,183,0.89 [0.72-1.11],0.3010400488012136
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of liver,27492,813,0.98 [0.88-1.08],0.6943199425386668
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",25274,4648,1.06 [1.02-1.11],0.0070383170702039
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27125,590,1.04 [0.92-1.17],0.5410675559588773
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27473,544,1.08 [0.95-1.22],0.2568225192005662
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26653,118,1.07 [0.82-1.41],0.6036110788777173
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26500,62,1.05 [0.72-1.52],0.8044600256146042
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27288,1423,1.11 [1.02-1.20],0.0104814335836861
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of tongue,26511,112,0.97 [0.73-1.28],0.8276176663562049
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26716,1601,1.02 [0.95-1.10],0.5811966355971667
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,22861,3225,0.99 [0.94-1.04],0.6002532593109455
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Duodenal ulcer,20757,131,0.92 [0.71-1.19],0.5220681148137605
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27544,111,0.80 [0.61-1.04],0.099832034900119
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27494,66,1.01 [0.70-1.46],0.9534481322428378
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,26772,93,1.27 [0.94-1.72],0.115171169423631
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19749,113,1.01 [0.77-1.33],0.941963430746754
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Functional dyspepsia,21285,659,0.98 [0.87-1.10],0.7358245295442367
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastric ulcer,20977,351,1.21 [1.03-1.41],0.0192655276426016
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23445,2819,1.03 [0.97-1.09],0.3505672887486829
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,21101,475,1.16 [1.02-1.33],0.0291740457354769
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,21597,8512,1.03 [1.00-1.06],0.0896458917347742
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,GI-bleeding,27013,1148,1.09 [1.00-1.19],0.0416563170791187
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26597,62,1.03 [0.71-1.49],0.8657494034494373
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,20623,1280,1.03 [0.95-1.12],0.5323268500962841
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",26717,38,0.75 [0.47-1.18],0.2084539350432322
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Hernia,26404,2908,1.07 [1.02-1.13],0.0122934138777628
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Impacted teeth,27505,61,1.01 [0.69-1.48],0.9541066441923644
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Impaction of intestines,19701,65,0.99 [0.68-1.43],0.944559601580076
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Inguinal hernia,23661,165,1.13 [0.90-1.43],0.2985438550706251
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,19739,103,1.36 [1.01-1.82],0.0406802326605538
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26047,182,1.52 [1.22-1.90],0.0001655284761636
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20459,823,1.11 [1.00-1.23],0.0517919309694101
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27579,356,0.83 [0.72-0.97],0.019275176217798
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26397,824,0.97 [0.87-1.07],0.5414926215853444
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26687,1114,1.02 [0.93-1.11],0.7165514130027411
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20787,161,1.01 [0.80-1.27],0.9426367724177224
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophagitis,21192,566,1.06 [0.94-1.20],0.3311911445367412
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27549,156,1.10 [0.87-1.39],0.4408760457984219
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23556,60,0.80 [0.55-1.16],0.2383715446573978
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20919,1283,1.03 [0.95-1.12],0.4455159847890807
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25416,301,1.06 [0.89-1.25],0.5048014793615825
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,25306,191,0.91 [0.74-1.13],0.4070143581641664
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestine,21230,1594,1.01 [0.94-1.09],0.7068917471849963
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,25411,5775,1.02 [0.98-1.06],0.4175893696334546
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26501,230,1.10 [0.91-1.34],0.3315437320877976
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of liver,27359,680,0.97 [0.87-1.09],0.6320083326718091
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,21211,585,1.18 [1.04-1.33],0.0085752219791298
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,25274,159,1.09 [0.86-1.37],0.4870629153104053
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27410,481,1.09 [0.96-1.25],0.190884860571263
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21709,1083,1.10 [1.00-1.20],0.0412290093510615
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27031,1166,1.11 [1.01-1.20],0.0227433506018513
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26729,194,1.05 [0.85-1.30],0.6294171562366855
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21429,1793,1.09 [1.01-1.17],0.0190607876339224
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),22738,2112,1.11 [1.04-1.19],0.0010398671266887
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,26778,99,1.20 [0.89-1.61],0.2284612330982339
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26554,981,0.99 [0.90-1.09],0.8090279710810531
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19971,335,1.06 [0.90-1.25],0.4619073012988136
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27483,74,1.04 [0.74-1.47],0.8204129478154144
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,20135,499,1.09 [0.96-1.25],0.1982595045388158
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",25997,132,0.89 [0.69-1.15],0.3662993823795156
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27588,70,0.99 [0.69-1.40],0.9348599329363976
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26537,129,1.14 [0.88-1.48],0.335891700866723
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Toxic colitis,25638,65,0.82 [0.57-1.17],0.2640971965955118
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20860,234,1.03 [0.85-1.25],0.7632137508183372
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ulcerative colitis,25744,171,1.11 [0.89-1.39],0.3658740647310323
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25713,140,1.13 [0.88-1.45],0.3462864854396115
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Umbilical hernia,23666,170,1.08 [0.87-1.35],0.4961756157104056
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,19827,191,1.18 [0.95-1.46],0.1438508893585124
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Ventral hernia,23754,258,1.02 [0.85-1.22],0.831189584971638
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Volvulus,19720,84,0.89 [0.65-1.24],0.4994939987549838
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27509,262,0.96 [0.80-1.16],0.682189394201477
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27272,75,1.15 [0.82-1.62],0.4151767515296908
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25518,221,0.84 [0.69-1.02],0.0715194165386917
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27061,625,1.09 [0.97-1.22],0.1698620799476076
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26581,145,0.96 [0.76-1.22],0.7494242630679937
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,25638,341,1.22 [1.04-1.43],0.0150017328896849
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27276,280,1.10 [0.93-1.31],0.2755464918910245
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27483,487,1.13 [0.99-1.29],0.0635881209121014
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27048,52,1.46 [0.98-2.19],0.0648853056227295
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25982,3183,1.04 [0.99-1.09],0.1627902368870283
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27143,486,0.99 [0.87-1.13],0.9154144756387426
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,26992,335,1.01 [0.86-1.18],0.9282730370354124
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27273,837,1.09 [0.99-1.21],0.0839288824474433
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27575,79,0.75 [0.55-1.03],0.073446275640563
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,25386,89,1.77 [1.30-2.41],0.0002595379537586
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26703,46,1.11 [0.72-1.72],0.6242275822054482
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27260,264,1.14 [0.95-1.36],0.1671643138280712
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25717,420,1.06 [0.92-1.23],0.4034485947394007
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,25345,48,0.99 [0.65-1.53],0.979691227318168
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27487,81,1.24 [0.89-1.72],0.1985898163395249
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26589,153,1.57 [1.24-1.99],0.0001754616434944
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27366,169,1.10 [0.88-1.38],0.4008825810370905
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27054,58,1.73 [1.18-2.52],0.0047325252108443
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,25363,66,1.18 [0.82-1.70],0.3759128742151429
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26901,1604,1.09 [1.02-1.18],0.0170528267686054
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25753,456,1.09 [0.95-1.26],0.2003577792710397
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,25350,53,0.87 [0.58-1.31],0.5059689047964557
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27509,312,1.01 [0.86-1.19],0.8944403108724069
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27079,83,0.79 [0.57-1.08],0.131845577237271
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27434,237,1.12 [0.93-1.36],0.2328902224241343
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27545,298,0.99 [0.84-1.18],0.93657182615897
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25456,159,0.76 [0.61-0.96],0.018505245766845
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25558,261,1.01 [0.84-1.21],0.9224645058151524
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27531,284,0.97 [0.82-1.16],0.7578847685052941
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",25498,201,1.54 [1.25-1.89],3.701888598584101e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27559,153,1.16 [0.91-1.47],0.2309047385094185
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,23553,127,0.83 [0.64-1.08],0.1621273806054006
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,25059,6426,1.03 [0.99-1.07],0.1570769502281175
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,23663,5030,1.05 [1.01-1.09],0.0221243845591389
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,23504,78,0.95 [0.68-1.31],0.73881459951049
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23670,154,0.95 [0.75-1.21],0.6990714117572454
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23724,208,1.19 [0.97-1.46],0.0891196825243589
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,27306,111,0.96 [0.73-1.26],0.7737527258099853
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",23636,120,1.12 [0.85-1.46],0.4306281682266134
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,20014,1381,1.08 [1.00-1.17],0.0608320077614521
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27442,228,1.14 [0.94-1.39],0.1856645496132796
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24127,611,1.09 [0.97-1.23],0.1399196613025086
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,23192,8167,1.03 [0.99-1.06],0.1313637690771799
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24717,136,1.21 [0.94-1.56],0.1424326366687612
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,23561,135,1.33 [1.03-1.71],0.0290319623548344
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24116,690,1.16 [1.04-1.30],0.0090479244967616
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26572,3056,1.04 [0.99-1.10],0.1397950965997285
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23605,179,1.06 [0.85-1.32],0.6065952473888849
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,23803,377,1.10 [0.95-1.28],0.2056363162417156
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23598,172,1.21 [0.97-1.52],0.0939116469842042
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,26642,108,0.91 [0.68-1.20],0.4971139840862026
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,20533,1900,0.95 [0.89-1.02],0.1594917040450754
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18856,223,1.04 [0.86-1.27],0.6619467001546433
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27583,220,1.04 [0.86-1.27],0.6721995319678922
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18733,100,0.92 [0.68-1.23],0.5636991770175008
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19211,578,1.00 [0.89-1.14],0.9496395836778831
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23758,332,0.92 [0.78-1.08],0.3113170025051728
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19274,641,0.95 [0.85-1.07],0.4309090503190895
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,23585,69,1.61 [1.12-2.29],0.0092343438828542
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24242,726,1.05 [0.94-1.17],0.4009724986255139
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23849,333,0.95 [0.81-1.12],0.5547374353521408
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19231,598,0.94 [0.83-1.05],0.2741982393604001
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,23521,95,1.07 [0.79-1.45],0.6505379479505498
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",23495,69,1.08 [0.76-1.54],0.6534815522731883
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,24631,50,1.23 [0.81-1.86],0.3319180579556536
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27114,2533,1.15 [1.09-1.22],2.381456271778714e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26412,1831,1.20 [1.12-1.28],4.722929836871789e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27394,604,1.06 [0.94-1.19],0.3308216667987753
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21697,3064,1.08 [1.02-1.14],0.0056150498583155
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18705,72,1.13 [0.80-1.60],0.4942073046179154
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,23528,102,1.32 [0.99-1.77],0.0565404661347644
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18676,43,1.47 [0.93-2.30],0.0968692063387949
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18838,205,1.08 [0.88-1.33],0.4430564882403898
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24870,289,0.87 [0.74-1.04],0.1189898041851584
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,25173,592,1.21 [1.07-1.37],0.0023911572392007
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27565,114,1.28 [0.97-1.69],0.0809448432052563
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25574,2058,1.04 [0.98-1.11],0.232632396133475
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23558,132,1.07 [0.83-1.38],0.6100780261223505
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18863,230,1.12 [0.92-1.36],0.2680850673197058
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24341,825,0.96 [0.87-1.07],0.4725904093112076
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,21193,2560,1.02 [0.96-1.08],0.4674114747970072
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,26667,133,1.06 [0.82-1.37],0.6342773670703385
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27575,75,1.18 [0.84-1.66],0.3347824296570774
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23507,81,0.97 [0.70-1.35],0.8645204552143837
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24918,1492,1.07 [0.99-1.15],0.0973707797175115
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,23510,84,1.08 [0.78-1.48],0.6583038280315718
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,20642,2009,1.06 [0.99-1.13],0.0906409171840088
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24716,135,0.84 [0.66-1.08],0.1730947985779905
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,23490,64,1.26 [0.87-1.82],0.2158072644330829
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,23718,202,1.02 [0.83-1.25],0.8644044970760715
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24020,594,1.19 [1.06-1.35],0.0036559433468952
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27045,511,1.06 [0.93-1.21],0.3923250055430166
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24170,654,1.17 [1.05-1.32],0.0061288059017046
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27409,584,1.08 [0.96-1.22],0.2101925874111828
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27566,68,1.62 [1.13-2.32],0.0084730297703286
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23651,225,1.11 [0.91-1.35],0.312074823323868
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,21180,921,1.09 [0.99-1.20],0.0673484849472006
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24101,675,1.05 [0.94-1.18],0.3822460667297538
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23552,126,0.95 [0.73-1.24],0.6999201822167682
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18709,76,1.04 [0.74-1.46],0.8170736649395003
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21296,2663,1.05 [0.99-1.11],0.0994914366980081
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19479,846,1.12 [1.02-1.25],0.0243048853044491
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,26834,300,0.92 [0.78-1.09],0.3378633411305183
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27535,84,1.33 [0.96-1.83],0.085541818095688
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",25275,55,1.12 [0.76-1.65],0.5770051041648279
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18709,76,1.20 [0.85-1.69],0.2938353636230252
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,23626,110,1.21 [0.91-1.60],0.1889146367461301
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19241,608,1.06 [0.94-1.19],0.3495396419736682
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23758,332,1.05 [0.89-1.23],0.582648971055151
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23801,285,1.21 [1.02-1.44],0.0329199866007976
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,23795,279,1.14 [0.95-1.36],0.1522730753762902
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,21307,83,0.95 [0.69-1.31],0.7547423456708794
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27573,75,1.54 [1.09-2.16],0.0134863341041221
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24069,643,0.95 [0.85-1.07],0.392216342096983
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],26696,162,1.38 [1.09-1.73],0.0065584593302959
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26265,2839,1.06 [1.00-1.12],0.0410411141530991
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23582,156,1.08 [0.86-1.37],0.5089761735361359
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,24089,573,1.08 [0.96-1.23],0.1972612738138681
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,25866,267,0.99 [0.83-1.18],0.8958640317152224
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,23797,281,1.05 [0.88-1.26],0.554223877416308
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25298,1782,1.04 [0.97-1.12],0.2577357935025164
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24730,1214,1.06 [0.97-1.15],0.1991940103491459
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],23490,64,1.46 [1.02-2.09],0.0410914923405108
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26755,221,1.27 [1.04-1.55],0.0164732131807953
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23627,201,1.24 [1.01-1.53],0.0403455482815426
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,23555,129,1.08 [0.83-1.39],0.5637964055186866
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18688,55,1.00 [0.67-1.50],0.9813876606925755
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26516,1263,1.31 [1.21-1.42],1.3556259223106248e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20659,101,0.91 [0.68-1.21],0.519171213053627
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26895,111,1.03 [0.78-1.36],0.8407795079096042
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27433,234,0.97 [0.80-1.17],0.7215859073912325
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27227,28,1.05 [0.60-1.82],0.8737604156177866
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26749,1496,1.44 [1.34-1.56],1.1922161683723037e-21
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27420,78,1.49 [1.08-2.07],0.0155820787979562
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27388,238,1.04 [0.86-1.26],0.6778806727691505
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Cystitis,24336,253,1.20 [1.00-1.45],0.0494921979843397
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Dialysis,25306,53,1.81 [1.22-2.68],0.0031429699606388
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27128,344,0.91 [0.78-1.06],0.2302926366070933
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,20738,180,0.97 [0.78-1.21],0.8054841886180258
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",20958,400,0.87 [0.75-1.00],0.0510968183594642
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21574,1016,0.94 [0.86-1.03],0.2184931205954311
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21486,5099,1.06 [1.02-1.11],0.0030882376418874
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27406,64,2.34 [1.64-3.32],2.274226274776916e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,25130,215,1.16 [0.95-1.42],0.1418682692280165
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27043,404,0.89 [0.77-1.03],0.1223082036001802
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27127,130,0.76 [0.59-0.97],0.0265583058753252
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,20866,308,0.89 [0.76-1.05],0.1712543133520006
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24162,79,1.41 [1.01-1.96],0.042011520777057
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23026,2468,0.99 [0.93-1.05],0.636705681185184
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20697,139,1.16 [0.90-1.49],0.241623480158619
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27581,66,1.02 [0.71-1.45],0.933665590173134
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27586,76,1.04 [0.74-1.45],0.8375046103649096
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26341,2258,1.08 [1.01-1.15],0.0157775489400122
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24565,482,1.02 [0.89-1.16],0.8178622449347678
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26904,120,0.70 [0.55-0.91],0.0064508649940241
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27534,384,1.12 [0.96-1.30],0.1543107969896352
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27532,93,0.77 [0.57-1.04],0.0866747717540967
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26019,1936,1.10 [1.02-1.17],0.0076186693629827
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26847,208,0.86 [0.71-1.05],0.1408247530446807
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20712,154,0.94 [0.74-1.19],0.6202085142475084
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20930,372,0.93 [0.80-1.08],0.3131151876382221
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20671,113,1.04 [0.78-1.37],0.7995514726276475
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20762,204,0.96 [0.78-1.17],0.6748022943863043
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25181,266,1.16 [0.97-1.39],0.1066186243558721
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,27273,123,1.14 [0.88-1.49],0.3283069012953714
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20872,314,1.06 [0.90-1.25],0.4879021604256326
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20666,108,0.98 [0.74-1.30],0.8776354879000237
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21208,650,0.95 [0.85-1.06],0.3739319591210153
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20718,160,1.12 [0.88-1.41],0.3563411644780427
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21142,584,1.06 [0.94-1.20],0.3073538746713461
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27379,37,1.31 [0.81-2.12],0.2749511049688354
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27400,2485,1.26 [1.19-1.34],6.223652317893137e-15
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",25081,166,1.07 [0.85-1.34],0.5762311171299972
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25353,100,1.31 [0.98-1.76],0.0720499961902544
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27233,34,1.17 [0.71-1.93],0.5301030529967843
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24231,148,1.19 [0.93-1.52],0.1573467280055528
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27466,267,0.98 [0.82-1.17],0.7970418731524018
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20698,140,0.93 [0.73-1.19],0.5864609512214786
